Research comparison
A side-by-side comparison of CJC 1295 (with DAC) and CJC 1295 (without DAC) as they are characterised in the peer-reviewed research literature. GHRH analogue research. Both compounds are supplied for in-vitro laboratory research only.
| CJC 1295 (with DAC) | CJC 1295 (without DAC) | |
|---|---|---|
| Research area | GHRH / Secretagogue Research | GHRH / Secretagogue Research |
| Sizes stocked | 2mg, 5mg, 10mg | 2mg, 5mg, 10mg |
| Reference | Full CJC 1295 (with DAC) page → | Full CJC 1295 (without DAC) page → |
CJC 1295 with Drug Affinity Complex (DAC) is a synthetic GHRH analogue with a maleimide-linked DAC modification designed to bind serum albumin, extending the compound's half-life in characterised research models. Supplied as lyophilised powder for in-vitro research use only.
CJC 1295 without DAC, also known in the literature as Mod GRF 1-29, is a synthetic GHRH analogue comprising the first 29 amino acids of GHRH with four amino-acid substitutions for stability. Supplied as lyophilised powder for in-vitro research use only.
Both compounds are characterised in the research literature within ghrh analogue research. Researchers typically consult the primary peer-reviewed publications for each compound before selecting one for a specific experimental protocol. The two are frequently studied in parallel and occasionally cited together in comparative pharmacology reviews.
Both CJC 1295 (with DAC) and CJC 1295 (without DAC) are supplied as lyophilised powder and reconstituted with bacteriostatic water using standard laboratory technique. For full reconstitution methodology see our Research Handling Guide, or compute resulting mg/ml concentrations with the Reconstitution Volume Calculator.
Every batch of both compounds is independently HPLC-verified by Janoshik Analytical at 99%+ purity. The lab report is supplied with every order and carries a unique verification key.